• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Ventripoint Diagnostics Ltd (OP:VPTDF)

    0.0900 -0.0048 (-5.06%)
    Streaming Delayed Price Updated: 9:30 AM EST, Jan 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Ventripoint Diagnostics Ltd

    News headline image
    AI Diagnostics: The End of the High-Cost Imaging Era
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    THE SCARCITY DOCTRINE: 5 Assets Securing the 2026 Material Cycle
    Issued on behalf of Ventripoint Diagnostics Ltd. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    THE FOUNDATION TRADE: 5 Assets Anchoring the Next Industrial Cycle
    Issued on behalf of GoldHaven Resources Corp. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    THE VISIBILITY INDEX: 5 Companies Solving the Invisible Crisis
    Issued on behalf of Ventripoint Diagnostics Ltd. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    Healthcare AI Exits Pilot Phase, Enters Production Deployment
    Issued on behalf of VentriPoint Diagnostics Ltd. 
    From Equity Insider
    Via GlobeNewswire
    News headline image
    From Hype to P&L: Hospitals Now Buying AI That Pays
    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
    Issued on behalf of Oncolytics Biotech Inc. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    UPDATE -- The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
    Issued on behalf of Oncolytics Biotech Inc. 
    From USA News Group
    Via GlobeNewswire
    News headline image
    The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
    Issued on behalf of Oncolytics Biotech Inc. 
    From USA News Group
    Via GlobeNewswire
    Ventripoint's Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
    Toronto, Ontario - TheNewswire - (October 11, 2024) - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT; OTCQB:VPTDF) is pleased to announce that it has submitted its next... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Welcomes Evelina London Children's Hospital as Newest VMS+ User
    Toronto, Ontario – TheNewswire – August 22, 2023 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) is pleased to announce that Evelina London Children’s Hospital... 
    Via TheNewswire.com
    Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options
    Toronto, Ontario – TheNewswire – April 1, 2022 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce that it will be exhibiting at the 71st... 
    Via TheNewswire.com
    Ventripoint Announces Patent Application for Improved Heart Analysis
    Toronto, Ontario – TheNewswire – August 09, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has filed an international patent application under the Patent... 
    Via TheNewswire.com
    Topics Artificial Intelligence Intellectual Property
    Ventripoint Engages Digital257 for Social Media and Investor Relations Services
    Toronto, Ontario – TheNewswire – July 5, 2021 - Ventripoint Diagnostics Ltd. (" Ventripoint " or the " Company "), (TSXV:VPT ) ; (OTC:VPTDF) is pleased to announce that it has engaged Digital257... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Issues Option Grants to Consultants and a Director of the Corporation
    Toronto, Ontario – TheNewswire – July 2, 2021 - Ventripoint Diagnostics Ltd. (“ Ventripoint ” or the “ Corporation ”) (TSXV:VPT) (OTC:VPTDF) announces that on July 1, 2021 the Board of Directors... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Announces Sponsorship for the 54th Annual Meeting of the Association of European Paediatric and Congenital Cardiology
    Ventripoint Also Provides a Financial Update 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint update on its Financial Status and on Warrant and Option Exercises
    Toronto, Ontario – TheNewswire – May 6, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to provide this update on its financial status and the... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Receives Government Funding to Advance Development of Next Generation of VMS+
    Toronto, Ontario – TheNewswire – May 4, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is excited to announce that it is receiving advisory services and... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Collaborates with GE Healthcare to Bring More Functionality to its Cardiac Ultrasound Devices
    Toronto, Ontario - The Newswire - April 27, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) announces the Company has entered into a collaboration with GE... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Attends 23rd Annual Canadian Echo Weekend and Grants Stock Options
    Toronto, Ontario – TheNewswire – April 20, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) attended the 23rd Annual Canadian Echo Weekend – 2021 Digital... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Extends Patent Portfolio with Foundational U.S. Provisional Patent Filing of Heart Motion Tracking Technology
    Toronto, Ontario - The Newswire - April 19, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT) (OTC:VPTDF) has filed a U.S. provisional patent application for its novel... 
    Via TheNewswire.com
    Topics Artificial Intelligence Intellectual Property
    Ventripoint Announces Sponsorship for the 2021 Canadian Society of Echocardiography Weekend Conference
    Toronto, Ontario – TheNewswire – April 15, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) is pleased to announce its sponsorship of the 2021 Canadian... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Ventripoint Diagnostics Begins Publication of Case Studies Showing Meritorious Use of the VMS Heart Analysis System
    Toronto, Ontario – TheNewswire – April 13, 2021 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company"), (TSXV:VPT); (OTC:VPTDF) has published its first case study of the meritorious use of the... 
    Via TheNewswire.com
    Topics Artificial Intelligence
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.